Striatal muscarinic receptors: regulation by dopaminergic agonists.
Striatal muscarinic receptors: regulation by dopaminergic agonists.
复制标题
纹状体毒蕈碱受体:多巴胺能激动剂的调节。
DOI:
10.1016/0024-3205(81)90512-9
复制
发表时间:
1981
期刊:
影响因子:
6.1
通讯作者:
Yamamura,HI
中科院分区:
文献类型:
--
作者:
Ehlert,FJ;Roeske,WR;Yamamura,HI
The effects of apomorphine on the binding properties of striatal muscarinic receptors were investigated using the specific muscarinic antagonist, [3H](−)3-quinuclidinyl benzilate ([3H](−)QNB). When binding measurements were made in 50 mM sodium/HEPES buffer, pH 7.4, containing Mg+2, the binding of [3H](−)QNB was consistent with the presence of two binding sites; 57% of the sites had a high affinity dissociation constant of 0.030 nM whereas the remaining sites had a low affinity dissociation constant of 0.64 nM. Apomorphine (1.0 μM) enhanced the binding of [3H](−)QNB by an apparent conversion of low to high affinity sites. A variety of other agents were screened for their ability to enhance [3H](−)QNB binding, and a pattern generally consistent with a dopaminergic effect was observed although some evidence for a β-adrenergic effect was demonstrable. The potent neuroleptics haloperidol, spiperone and sulpiride failed to antagonize the apomorphine enhancement of [3H](−)QNB binding as well as some adrenergic antagonists. However, the potent inhibitors of the dopamine-sensitive adenylate cyclase, α-flupenthixol and fluphenazine, specifically blocked the apomorphine enhancement of [3H](−)QNB binding with Kivalues of approximately 0.1 μM.